DK119577A - Peptid samt fremgangsmade til fremstilling deraf - Google Patents

Peptid samt fremgangsmade til fremstilling deraf

Info

Publication number
DK119577A
DK119577A DK119577A DK119577A DK119577A DK 119577 A DK119577 A DK 119577A DK 119577 A DK119577 A DK 119577A DK 119577 A DK119577 A DK 119577A DK 119577 A DK119577 A DK 119577A
Authority
DK
Denmark
Prior art keywords
peptime
procedures
manufacture
Prior art date
Application number
DK119577A
Other languages
English (en)
Other versions
DK149111B (da
DK149111C (da
Inventor
M Jujino
O Nishimura
Y Nagawa
N Fukuda
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of DK119577A publication Critical patent/DK119577A/da
Publication of DK149111B publication Critical patent/DK149111B/da
Application granted granted Critical
Publication of DK149111C publication Critical patent/DK149111C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/12—1,4-Thiazines; Hydrogenated 1,4-thiazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK119577A 1976-03-23 1977-03-18 Analogifremgangsmaade til fremstilling af histidinderivater eller syreadditionssalte deraf DK149111C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3217076 1976-03-23
JP51032170A JPS5944308B2 (ja) 1976-03-23 1976-03-23 ペプタイド

Publications (3)

Publication Number Publication Date
DK119577A true DK119577A (da) 1977-09-24
DK149111B DK149111B (da) 1986-01-27
DK149111C DK149111C (da) 1986-06-09

Family

ID=12351453

Family Applications (1)

Application Number Title Priority Date Filing Date
DK119577A DK149111C (da) 1976-03-23 1977-03-18 Analogifremgangsmaade til fremstilling af histidinderivater eller syreadditionssalte deraf

Country Status (19)

Country Link
US (1) US4100152A (da)
JP (1) JPS5944308B2 (da)
AT (1) AT360674B (da)
AU (1) AU508387B2 (da)
BE (1) BE852740A (da)
CA (1) CA1060435A (da)
CH (1) CH634548A5 (da)
DE (1) DE2712086C2 (da)
DK (1) DK149111C (da)
FR (1) FR2345448A1 (da)
GB (1) GB1579264A (da)
GR (1) GR62565B (da)
HK (1) HK27584A (da)
HU (1) HU177515B (da)
MY (1) MY8500264A (da)
NL (1) NL188412C (da)
SE (1) SE430601B (da)
SG (1) SG76083G (da)
ZA (1) ZA771495B (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU180926B (en) * 1979-06-28 1983-05-30 Richter Gedeon Vegyeszet Process for preparing trh analogues,tripeptide amides infectives on the central nerve sysrhem
US4591648A (en) * 1981-04-01 1986-05-27 National Research Development Corp. Histidine protection
US4426378A (en) 1981-04-09 1984-01-17 The United States Of America As Represented By The Secretary Of The Army Thyrotropin releasing hormone in therapy of shock and as a central nervous system stimulant
JPS5849313A (ja) * 1981-09-16 1983-03-23 Takeda Chem Ind Ltd 抗てんかん剤
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
GB2146026A (en) * 1983-09-07 1985-04-11 Tanabe Seiyaku Co Peptides and process for preparing the same
JPS60190795A (ja) * 1984-03-09 1985-09-28 Takeda Chem Ind Ltd ペプタイド
US4608365A (en) * 1984-03-30 1986-08-26 University Of Southern California Treatment of neurologic functions
IL75641A (en) * 1984-07-10 1990-11-05 Tanabe Seiyaku Co 1-methyl-4,5-dihydro-orotyl-histidyl-prolinamide,its preparation and pharmaceutical compositions comprising it
GB2171101A (en) * 1985-02-20 1986-08-20 Tanabe Seiyaku Co Peptide and processes for preparation of the same
FR2585709B1 (fr) * 1985-08-05 1987-10-02 Adir Nouveaux derives peptidiques a structure lactonique ou cycloamidique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP2526589B2 (ja) * 1986-08-08 1996-08-21 武田薬品工業株式会社 ペプチド含有マイクロカプセルおよびその製造法
US5686420A (en) * 1987-06-05 1997-11-11 Georgetown University Thyrotropin-releasing hormone analogs and method of use
JPS63316724A (ja) * 1987-06-19 1988-12-26 Nippon Shinyaku Co Ltd 抗けいれん剤
US5151497A (en) * 1989-02-21 1992-09-29 Japan Tobacco Inc. Histidyl peptide derivatives
CA2050425A1 (en) 1990-09-03 1992-03-04 Yoshiaki Uda Pharmaceutical composition and its mucous use
NZ240214A (en) 1990-10-16 1993-02-25 Takeda Chemical Industries Ltd Polymer compositions comprising a polylactic acid and a copolymer of glycolic acid and a hydroxycarboxylic acid; use as carrier for prolonged release pharmaceutical compositions of water soluble drugs
US5416071A (en) * 1991-03-12 1995-05-16 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release containing epo and hyaluronic acid
EP0582459B1 (en) 1992-08-07 1998-01-07 Takeda Chemical Industries, Ltd. Production of microcapsules of water-soluble drugs
US6117455A (en) * 1994-09-30 2000-09-12 Takeda Chemical Industries, Ltd. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
US5837281A (en) 1995-03-17 1998-11-17 Takeda Chemical Industries, Ltd. Stabilized interface for iontophoresis
AU713030B2 (en) * 1995-10-24 1999-11-18 Gruenenthal Gmbh Method of adjusting the circadian rhythm of a mammal
CA2192782C (en) 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
US5908400A (en) * 1996-06-20 1999-06-01 Hisamitsu Pharmaceutical Co., Inc. Device structure for iontophoresis
CN1214040C (zh) * 1996-08-28 2005-08-10 盐野义制药株式会社 具有噻唑基－丙氨酸残基的新型肽类衍生物
JP2001520222A (ja) * 1997-10-22 2001-10-30 ゼネカ・リミテッド イミダゾール誘導体およびファルネシルタンパク質トランスフェラーゼインヒビターとしてのそれらの使用
PT1025088E (pt) 1997-10-22 2002-01-30 Astrazeneca Ab Derivados de imidazole e sua utilizacao como inibidores de farnesil proteino transferase
JP2003528088A (ja) * 2000-03-23 2003-09-24 メルク エンド カムパニー インコーポレーテッド メラノコルチン受容体作働薬としての置換ピペリジン類
WO2002017954A1 (fr) * 2000-08-31 2002-03-07 Shionogi & Co., Ltd. Medicaments contre la maladie de parkinson
CA2430934C (en) 2000-12-01 2011-06-21 Takeda Chemical Industries, Ltd. A method of producing sustained-release preparations of a bioactive substance using high-pressure gas
GB0326632D0 (en) 2003-11-14 2003-12-17 Jagotec Ag Dry powder formulations
WO2012028745A1 (en) 2010-09-03 2012-03-08 Pharmaterials Limited Pharmaceutical composition suitable for use in a dry powder inhaler
EP2873422A4 (en) 2012-07-10 2015-12-30 Takeda Pharmaceutical PHARMACEUTICAL PREPARATION FOR INJECTION

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3753969A (en) * 1969-12-22 1973-08-21 K Folkers Method for synthesizing pyroglutamylhistidyl-prolinamide
US3821188A (en) * 1972-06-14 1974-06-28 American Home Prod Proline and pyroglutamic acid containing tripeptides
US3959248A (en) * 1974-04-03 1976-05-25 Merck & Co., Inc. Analogs of thyrotropin-releasing hormone
DE2449167C2 (de) * 1974-10-16 1984-05-24 Grünenthal GmbH, 5190 Stolberg N-Acyl-L-histidyl-L-prolinamide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen

Also Published As

Publication number Publication date
FR2345448A1 (fr) 1977-10-21
US4100152A (en) 1978-07-11
HU177515B (en) 1981-10-28
NL188412C (nl) 1992-06-16
SE430601B (sv) 1983-11-28
SG76083G (en) 1984-08-03
SE7703283L (sv) 1977-09-24
AU508387B2 (en) 1980-03-20
MY8500264A (en) 1985-12-31
NL7703115A (nl) 1977-09-27
AU2354977A (en) 1978-09-28
JPS5944308B2 (ja) 1984-10-29
FR2345448B1 (da) 1980-06-27
HK27584A (en) 1984-03-30
GB1579264A (en) 1980-11-19
CH634548A5 (de) 1983-02-15
DE2712086A1 (de) 1977-09-29
NL188412B (nl) 1992-01-16
CA1060435A (en) 1979-08-14
AT360674B (de) 1981-01-26
ATA202377A (de) 1980-06-15
GR62565B (en) 1979-05-10
ZA771495B (en) 1978-02-22
JPS52116465A (en) 1977-09-29
BE852740A (fr) 1977-07-18
DK149111B (da) 1986-01-27
DK149111C (da) 1986-06-09
DE2712086C2 (de) 1986-04-03

Similar Documents

Publication Publication Date Title
DK119577A (da) Peptid samt fremgangsmade til fremstilling deraf
DK313977A (da) Kateter samt fremgangsmade til fremstilling deraf
DK119276A (da) Non-thrombogen medicinsk genstand samt fremgangsmade til fremstilling deraf
DK357677A (da) Bererfikserede enzymer samt fremgangsmade til fremstilling og anvendelse heraf
DK397777A (da) Thiazolindinderivater samt fremgangsmaade til fremstilling deraf
DK21079A (da) Substituerede heterocycloske benzamider samt fremgangsmaade til fremstilling deraf
ATA77677A (de) Hangemappe
DK25177A (da) 1,2-benzisothiazolinoner-3 samt fremgangsmade til fremstilling deraf
DK545077A (da) Thiooximcephalosporin- og penicillinderivater samt fremgangsmaader til fremstilling deraf
DK388377A (da) Cephalosporiner samt fremgangsmaade til fremstilling deraf
SE7704322L (sv) Tiokarbamidderivat samt forfarande for framstellning derav
SE7609743L (sv) Blixtlas samt forfarande och anordning for dess framstellning
SE426691B (sv) Lera-cementbruk samt forfarande for framstellning av detsamma
DK303178A (da) Benzylpyrimidiner samt fremgangsmaade til fremstilling deraf
FI53275C (fi) Falsfog foer plastfolier samt hopfogningsapparat
DK402877A (da) 1-amino-2-hydroxy-3-heterocyclyloxy-propansalte deraf samt fremgangsmaade til fremstilling deraf
DK232977A (da) Farvede bituminose materialer samt fremgangsmade til fremstilling heraf
DK171077A (da) Aminoalkoholer
SE428320B (sv) Armerat plastror samt forfarande for framstellning derav
DK159160C (da) Nitroaryl-malto-n-osider samt fremgangsmaade til fremstilling deraf
DK313576A (da) 1-methyl-2-(phenyl-oxymethyl)-5-nitro-imidazoler samt fremgangsmade til fremstilling deraf
DK59277A (da) Naphthalenonphthalazinylhydrazoner samt fremgangsmade til fremstilling deraf
SE7611478L (sv) Sintringsforfarande samt anleggning for utforande av forfarandet
DK184277A (da) Fremgangsmade til dekoffeinering
DK329976A (da) 11,12-umettede 9alfa-fluorsteroider samt fremgangsmade til fremstilling deraf

Legal Events

Date Code Title Description
PBP Patent lapsed